Abstract
Ets family transcription factors, characterized by an evolutionary conserved Ets domain, play important roles in cell development, cell differentiation, apoptosis and tissue remodeling. All members of this family have an activation or a repression domain for DNA binding. The Ets domain has been shown to bind 5-GGAA/T-3 core motif of DNA by its wHTH (winged helix-turn-helix) structure, as determined by NMR or X-Ray crystallography analysis. A number of Ets transcription factors have been shown to be involved or directly implicated in the pathogenesis of a wide spectrum of human cancers. They are thus potential molecular targets for selective cancer therapy. Computer simulations using molecular dynamics allows monitoring the dynamics of individual atoms, thereby giving a unique insight into the structural flexibility of binary complexes between Ets-domain and a specific DNA sequence that cannot be easily extracted from laboratory experiments. Moreover, an understanding of structural motifs that influence the specificity of Ets domains is essential for antitumor drug design. Here we describe molecular and structural studies that provide a detailed description of the direct and indirect readout mechanisms of DNA recognition by Ets domains, a conserved mechanism observed in other DNA-protein complexes.
Keywords: Molecular dynamics, Ets domain, DNA binding site, structure
Current Bioinformatics
Title: Molecular Dynamics and Structural Studies of the Ets Domain-DNA Complexes
Volume: 2 Issue: 3
Author(s): Rafael A. Caceres, Claudia P. Nunes, Walter F. de Azevedo Jr., Luiz A. Basso and Diogenes S. Santos
Affiliation:
Keywords: Molecular dynamics, Ets domain, DNA binding site, structure
Abstract: Ets family transcription factors, characterized by an evolutionary conserved Ets domain, play important roles in cell development, cell differentiation, apoptosis and tissue remodeling. All members of this family have an activation or a repression domain for DNA binding. The Ets domain has been shown to bind 5-GGAA/T-3 core motif of DNA by its wHTH (winged helix-turn-helix) structure, as determined by NMR or X-Ray crystallography analysis. A number of Ets transcription factors have been shown to be involved or directly implicated in the pathogenesis of a wide spectrum of human cancers. They are thus potential molecular targets for selective cancer therapy. Computer simulations using molecular dynamics allows monitoring the dynamics of individual atoms, thereby giving a unique insight into the structural flexibility of binary complexes between Ets-domain and a specific DNA sequence that cannot be easily extracted from laboratory experiments. Moreover, an understanding of structural motifs that influence the specificity of Ets domains is essential for antitumor drug design. Here we describe molecular and structural studies that provide a detailed description of the direct and indirect readout mechanisms of DNA recognition by Ets domains, a conserved mechanism observed in other DNA-protein complexes.
Export Options
About this article
Cite this article as:
Caceres A. Rafael, Nunes P. Claudia, de Azevedo Jr. F. Walter, Basso A. Luiz and Santos S. Diogenes, Molecular Dynamics and Structural Studies of the Ets Domain-DNA Complexes, Current Bioinformatics 2007; 2 (3) . https://dx.doi.org/10.2174/157489307781662141
DOI https://dx.doi.org/10.2174/157489307781662141 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Advances in the Management of Brain Tumors in Infants
Current Cancer Therapy Reviews Drug Transport Across the Blood-Brain Barrier and the Impact of Breast Cancer Resistance Protein (ABCG2)
Current Topics in Medicinal Chemistry Metabotropic Glutamate Receptor 5 in Down's Syndrome Hippocampus During Development: Increased Expression in Astrocytes
Current Alzheimer Research Antagonists of CCR4 as Immunomodulatory Agents
Current Topics in Medicinal Chemistry Update on Myositis Therapy: From Today’s Standards to Tomorrow’s Possibilities
Current Pharmaceutical Design Induced Pluripotent Stem Cells (iPSCs) Derived from Different Cell Sources and their Potential for Regenerative and Personalized Medicine
Current Molecular Medicine Recent Progress in the Development of Adenosine Receptor Ligands as Antiinflammatory Drugs
Current Topics in Medicinal Chemistry Therapies of Hematological Malignancies: An Overview of the Potential Targets and Their Inhibitors
Current Chemical Biology Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology Editorial [Hot topic: The Urokinase Receptor System as Strategic Therapeutic Target: Challenges for the 21st Century (Executive Guest Editor: Bernard Degryse)]
Current Pharmaceutical Design Treatment of Diffuse-Type Gastric Cancer Cells Using 213Bi-Radioimmunoconjugates In Vitro and In Vivo Following Intraperitoneal Dissemination
Current Radiopharmaceuticals Brain Tumour Stem Cells: Implications for Cancer Therapy and Regenerative Medicine
Current Stem Cell Research & Therapy Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops
Current Signal Transduction Therapy Future Prospects for Targeted Alpha Therapy
Current Radiopharmaceuticals Drug Repurposing in Chemical Genomics: Can We Learn from the Past to Improve the Future?
Current Topics in Medicinal Chemistry Notch Signaling Proteins: Legitimate Targets for Cancer Therapy
Current Protein & Peptide Science The Control of Cell Cycle in Mouse Primordial Germ Cells: Old and New Players
Current Pharmaceutical Design CD45 Regulated Signaling Pathways
Current Topics in Medicinal Chemistry The Role of B Cell Receptor Stimulation in CLL Pathogenesis
Current Pharmaceutical Design Cytoplasmic CXCR4 High-Expression Exhibits Distinct Poor Clinicopathological Characteristics and Predicts Poor Prognosis in Triple-Negative Breast Cancer
Current Molecular Medicine